A clinical trial to study the effects of Green Coffee and Thyme (herb) in patient with high Cholesterol and raised sugar levels

Evaluation of Antihyperlipidemic Potential of Thyme Infused Green Coffee in Human Subjects

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/032458

Enrollment

150

Registered

2021-03-31

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Placebo: No Treatment Control Intervention1: Consumption of Green Coffee Powder: 1. Feeding of 2 grams of green coffee powder available in filtered tea bags with boiled water in the for

Eligibility

Inclusion criteria

Inclusion criteria: 1. Sedentary to Moderate worker 2. Serum Cholesterol more than 220 mg/dl 3. Fasting blood sugar level more than 90 mg/dl 4. Non Smokers

Exclusion criteria

Exclusion criteria: 1.Smokers 2. Pregnant and Lactating women 3. Humans with Liver, Renal and Muscle Diseases 4. Humans with Genetic disorders

Design outcomes

Primary

Measure	Time frame
Thyme infused green coffee may alter the lipid profile of subjects.Timepoint: 8 weeks and 12 weeks	—

Secondary

Measure	Time frame
Thyme infused green coffee may alter the BMI of subjects.Timepoint: 12 weeks	—

Countries

India

Contacts

Public ContactRicha Arora

Manav Rachna International Institute of Research and Studies

shubhra.fas@mriu.edu.in9990815505

Outcome results